Priority-setting in global health

Last updated

In global health, priority-setting is a term used for the process and strategy of deciding which health interventions to carry out. Priority-setting can be conducted at the disease level (i.e. deciding which disease to alleviate), the overall strategy level (i.e. selective primary healthcare versus primary healthcare versus more general health systems strengthening), research level (i.e. which health research to carry out), [1] or other levels. [2] : 5 

Contents

Definitions

Priority-setting is the act of deciding which health interventions to carry out, and can occur at several levels of granularity. Priority-setting can occur at the following levels: [1] [2] : 5  [3]

Synonymous terms include "prioritization in health care and health research", "priority determination", "health priorities", [4] and "agenda-setting". [5]

Metrics

Various metrics have been used to compare interventions. These include:

Who sets the priorities?

Priority-setting can be done by various actors. These include:

According to Devi Sridhar, professor of global health at the University of Edinburgh, [9] "the priorities of funding bodies largely dictate what health issues and diseases are studied". [10]

Usually at a level of equity and are done by decision-makers closely working alongside marginalized communities and people being influenced. Stakeholder engagement involvements is critical in priority-settings as it establishes if the decisions made by the various actors reflect what the population needs as well as if they are appropriate and accurate. [11] Priority setting decision-makers often make it a point to not only provide assistance and resources but to also give voices to those who are often unheard and invisible in the privileged system. [12] Oftentimes, these priorities address more than just socioeconomic status but also inequalities such as gender, race, and religion inequalities. [13] Policies take a long time to process because of how specific they tend to be.

Once a consensus has been reached between the priority setting makers and the communities, there might be challenges and problems that could arise based on the health intervention being pushed by the priority. Due to the complexity of the inequalities, aspects such as the levels of population health and the distribution of health are being considered which could also be looked at through economical lenses. [14] Although decision makers have the power to constraint and provide aid, there also tends to be an asymmetric information [15] as health organizations might overestimate which priorities are desired. [16]

History of organizations and programs working on priority-setting

Global-level priority-setting has occurred since at least the 1980s, though these efforts have only focused on a few aspects. [6]

The following table is a timeline of organizations and programs working on priority-setting.

Years activeEventLevel at which prioritization occurredMetric or methods usedOperating costs/funding level (in US$)Results and impact
1977–present WHO Model List of Essential Medicines is published. [6] Among medicinesProduced explicit list of medicines. As of 2016, at least 156 countries have created national lists of essential medicines based on the WHO's model list. [17]
1984 Demographic and Health Surveys is conceived. [18] Improving data quality [6] 380,000,000 (from USAID as of 2011) [18] Data from the DHS has been analyzed by various papers. [18]
1987–1989The Oregon Health Services Commission (HSC) is established to prioritize within the US Medicaid program. [6] The HSC would publish their first prioritized list of health services in 1993. [19] : 4  The HSC would be abolished in 2012. [20] Health services [19] Originally a cost-per-utility formula, but then expert judgment and a method of splitting health services into categories and ranking within categories [19] : 3 "This time greater emphasis is placed on preventive services and chronic disease management, reflecting the fact that providing health care before reaching crisis mode will prevent avoidable morbidity and mortality." [19]
1987–1990 Commission on Health Research for Development [1] is established in 1987 and would publish Health Research: Essential Link to Equity in Development in 1990. [21] ResearchMeetings with expertsProduced several reports, including the final report, Health Research: Essential Link to Equity in Development. Resulted in the establishment of the Council on Health Research for Development (COHRED) to promote priority-setting in low- and middle-income countries.
 ? Essential National Health Research
1993Disease Control Priorities in Developing Countries is published by the Disease Control Priorities Project. [6] [22] Disability-adjusted life year [4] [6]
1993The World Bank publishes the 1993 World Development Report. [6] Health interventions [23] : 14 Disability-adjusted life year [24]
1994 World Health Organization's Ad Hoc Committee on Health Research Relating to Future Intervention Options (AHC) [1] Research and developmentProduced the 1996 report "Investing in Health Research and Development".
1995 Multiple Indicator Cluster Surveys [6] Improving data quality
1998 WHO-CHOICE, a program that helps countries choose health system priorities, is developed. [4] [6] [25] [26]
1998 Global Forum for Health Research [1] Research and developmentStructured interviews and literature reviewProduced a list of 17 priorities.
2000 Council on Health Research and Development [1] Review of previous efforts
2001 Center for Global Development [27]
2002 Marginal budgeting for bottlenecks [4] (the World Bank, UNICEF, and WHO) is conceived.
2003The Bill & Melinda Gates Foundation announces the Grand Challenges in Global Health, [1] for which it initially provides $200 million in funding. [7] Research and developmentScientific board550,000,000 (from the Gates Foundation as of 2008; smaller amounts from others not yet included)Out of more than 1000 submissions, 14 were selected by the scientific board as "grand challenges". [1]
2003The initial version of the Lives Saved Tool (LiST) by Johns Hopkins University [4] [6] is created. [28]
2004 Global Forum for Health Research develops the "Combined Approach Matrix" (CAM). [1] Various (since CAM is a general method)CAM itself is the method, but takes into account disease burden, present level of knowledge, cost-effectiveness, macro-economic policies, etc.Rudan et al.: "The tool has proven to be highly useful for systematic classification, organization, and presentation of the large body of information that is needed at different stages of priority setting process, so that the decisions made by the members of decision-making committees could be based on all relevant and available information, rather than their own personal knowledge and judgment." [1]
2004The Copenhagen Consensus (which focuses on aid and development in general, and not just global health) holds its first conference. [2] : 5 
2005 Health Metrics Network launches. The partnership would dissolve in 2013. [29] Improving data quality [6] 50,000,000 (initially, by the Gates Foundation; see Health Metrics Network § Funding for more) Various
2006Second edition of Disease Control Priorities in Developing Countries by the Disease Control Priorities Project [30] is published. [22]
2007 The Lancet publishes a series of papers on priorities in international health. [1] Research Delphi method
2007 Health Intervention and Technology Assessment Program is established.Various
2007 Institute for Health Metrics and Evaluation launches.Improving data quality, burden of disease105,000,000 (initial grant, mainly from the Gates Foundation)
2008Supporting Independent Immunization and Vaccine Advisory Committees Initiative (SIVAC) is founded. [6] [31] Among vaccines
2009 EVIDEM Collaboration (Evidence and Value: Impact on Decision Making) is established. [6] [32] Health interventions [32] Literature review, "discussions with stakeholders", and multicriteria decision analysis (MCDA) [33]
2013 International Decision Support Initiative launches as the result of a Center for Global Development working group.Health interventions12,800,000 (from the Bill & Melinda Gates Foundation for phase 2 of operations) [34] [35]

Reception

The result of a myriad of actors championing a kaleidoscope of "priorities" is confusion. Advocates, researchers, and policy makers have labeled almost every disease, condition, medication, or intervention a "health priority."

— Glassman et al. [6]

Rudan et al. says that priority-setting efforts have relied on "consensus reached by panels of experts" and as a result have not been systematic enough, and that this has "often made it difficult to present the identified priorities to wider audiences as legitimate and fair". [1]

Glassman et al. notes that criticisms of priority-setting include "the weak data on which estimates of burden, cost, and effectiveness relied; the value judgments implicit in disability-adjusted life year age weighting and discounting decisions; and treatment of equity issues, as well as the political difficulties associated with translating a ground zero package into a public budget based on historical inputs"; and the consideration of only health maximization at the expense of other objectives such as fairness. [6] : 16 

Glassman et al. also notes how there are more cost-effectiveness studies for LMICs (in the thousands), but that these are unlikely to be actually applied to priority-setting processes. [6] : 16 

Jeremy Shiffman has said that some bodies such as the Institute for Health Metrics and Evaluation and The Lancet are prominent in priority-setting due to their dominion rather than data and analysis, and also notes that the process of creating the Sustainable Development Goals was not sufficiently transparent. [36]

See also

Related Research Articles

Cost-effectiveness analysis (CEA) is a form of economic analysis that compares the relative costs and outcomes (effects) of different courses of action. Cost-effectiveness analysis is distinct from cost–benefit analysis, which assigns a monetary value to the measure of effect. Cost-effectiveness analysis is often used in the field of health services, where it may be inappropriate to monetize health effect. Typically the CEA is expressed in terms of a ratio where the denominator is a gain in health from a measure and the numerator is the cost associated with the health gain. The most commonly used outcome measure is quality-adjusted life years (QALY).

<span class="mw-page-title-main">Preventive healthcare</span> Prevent and minimize the occurrence of diseases

Preventive healthcare, or prophylaxis is the application of healthcare measures to prevent diseases. Disease and disability are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices, and are dynamic processes which begin before individuals realize they are affected. Disease prevention relies on anticipatory actions that can be categorized as primal, primary, secondary, and tertiary prevention.

Community health refers to simple health services that are delivered by laymen outside hospitals and clinics. Community health is also the subset of public health that is taught to and practiced by clinicians as part of their normal duties. Community health volunteers and community health workers work with primary care providers to facilitate entry into, exit from and utilization of the formal health system by community members.

Male circumcision reduces the risk of human immunodeficiency virus (HIV) transmission from HIV positive women to men in high risk populations.

<span class="mw-page-title-main">Global health</span> Health of populations in a global context

Global health is the health of the populations in the worldwide context; it has been defined as "the area of study, research, and practice that places a priority on improving health and achieving equity in health for all people worldwide". Problems that transcend national borders or have a global political and economic impact are often emphasized. Thus, global health is about worldwide health improvement, reduction of disparities, and protection against global threats that disregard national borders, including the most common causes of human death and years of life lost from a global perspective.

<span class="mw-page-title-main">Primary health care</span> "Essential" health care key to securing universality by emphasizing community and equity

Primary health care (PHC) is "essential health care" that is based on scientifically sound and socially acceptable methods and technology. This makes universal health care accessible to all individuals and families in a community. PHC initiatives allow for the full participation of community members in implementation and decision making. Services are provided at a cost that the community and the country can afford at every stage of their development in the spirit of self-reliance and self-determination. In other words, PHC is an approach to health beyond the traditional health care system that focuses on health equity-producing social policy. PHC includes all areas that play a role in health, such as access to health services, environment and lifestyle. Thus, primary healthcare and public health measures, taken together, may be considered as the cornerstones of universal health systems. The World Health Organization, or WHO, elaborates on the goals of PHC as defined by three major categories, "empowering people and communities, multisectoral policy and action; and primary care and essential public health functions as the core of integrated health services[1]." Based on these definitions, PHC can not only help an individual after being diagnosed with a disease or disorder, but actively prevent such issues by understanding the individual as a whole.

Health promotion is, as stated in the 1986 World Health Organization (WHO) Ottawa Charter for Health Promotion, the "process of enabling people to increase control over, and to improve their health."

The social determinants of health (SDOH) are the economic and social conditions that influence individual and group differences in health status. They are the health promoting factors found in one's living and working conditions, rather than individual risk factors that influence the risk for a disease, or vulnerability to disease or injury. The distributions of social determinants are often shaped by public policies that reflect prevailing political ideologies of the area.

<span class="mw-page-title-main">Disability-adjusted life year</span> Measure of disease burden

The disability-adjusted life year (DALY) is a measure of overall disease burden, expressed as the number of years lost due to ill-health, disability or early death. It was developed in the 1990s as a way of comparing the overall health and life expectancy of different countries.

Multimorbidity, also known as multiple long-term conditions (MLTC), means living with two or more chronic illnesses. For example, a person could have diabetes, heart disease and depression at the same time. Multimorbidity can have a significant impact on people's health and wellbeing. It also poses a complex challenge to healthcare systems which are traditionally focused on individual diseases. Multiple long-term conditions are much more common in older people, affecting more than half of those over 65, however, they can also be found in young people.

Founded in 2001, the Child Health Nutrition Research Initiative (CHNRI) is a network of interested partners supported by the Global Forum for Health Research, based in Geneva, Switzerland. CHNRI efforts support the Millennium Development Goals of:

A public health intervention is any effort or policy that attempts to improve mental and physical health on a population level. Public health interventions may be run by a variety of organizations, including governmental health departments and non-governmental organizations (NGOs). Common types of interventions include screening programs, vaccination, food and water supplementation, and health promotion. Common issues that are the subject of public health interventions include obesity, drug, tobacco, and alcohol use, and the spread of infectious disease, e.g. HIV.

Comparative effectiveness research (CER) is the direct comparison of existing health care interventions to determine which work best for which patients and which pose the greatest benefits and harms. The core question of comparative effectiveness research is which treatment works best, for whom, and under what circumstances. Engaging various stakeholders in this process, while difficult, makes research more applicable through providing information that improves patient decision making.

Patient participation is a trend that arose in answer to medical paternalism. Informed consent is a process where patients make decisions informed by the advice of medical professionals.

<span class="mw-page-title-main">Institute for Health Metrics and Evaluation</span> Statistics institute for public health under the University of Washington, based in Seattle

The Institute for Health Metrics and Evaluation (IHME) is a research institute working in the area of global health statistics and impact evaluation at the University of Washington in Seattle. The Institute is headed by Christopher J.L. Murray, a physician and health economist, and professor at the University of Washington Department of Global Health, which is part of the School of Medicine. IHME conducts research and trains scientists, policymakers, and the public in health metrics concepts, methods, and tools. Its mission includes judging the effectiveness and efficacy of health initiatives and national health systems. IHME also trains students at the post-baccalaureate and post-graduate levels.

Verbal autopsy (VA) is a method of gathering information about symptoms and circumstances for a deceased individual to determine their cause of death. Health information and a description of events prior to death are acquired from conversations or interviews with a person or persons familiar with the deceased and analyzed by health professionals or computer algorithms to assign likely cause(s) of death.

The International Decision Support Initiative (iDSI) is a partnership between governments, universities, and thinktanks that helps health policy makers make better decisions. iDSI targets low- and middle-income countries (LMICs), helping them prioritize health interventions as a means toward universal health coverage. iDSI launched in November 2013 as the result of a 2012 Center for Global Development working group.

WHO-CHOICE is an initiative started by the World Health Organization in 1998 to help countries choose their healthcare priorities. It is an example of priority-setting in global health. It was one of the earliest projects to perform sectoral cost-effectiveness analyses on a global scale. Findings from WHO-CHOICE have shaped the World Health Report of 2002, been published in the British Medical Journal in 2012, and been cited by charity evaluators and academics alongside DCP2 and the Copenhagen Consensus.

<span class="mw-page-title-main">Igor Rudan</span>

Igor Rudan is a Croatian-British scientist, writer, and science communicator. He creates popular science books and documentaries.

Nachiappan Chockalingam, professionally known as Nachi Chockalingam is a British scientist, academic practitioner and expert in Clinical Biomechanics. He is a professor at Staffordshire University and a Fellow of the Institute of Physics and Engineering in Medicine and has been appointed to a panel of experts for the Research Excellence Framework. Between 2016 and 2022, he has contributed to the NIHR Research for Patient Benefit Panel and serves in multiple other review panels of global grant awarding bodies including the EPSRC, MRC and the European Commission. He contributed to development of podiatric biomechanics in the UK and played a pivotal role in the establishment of the journals such as the Footwear Science and is on the editorial panel for a number of scientific and clinical journals.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 Rudan I, Gibson J, Kapiriri L, Lansang MA, Hyder AA, Lawn J, et al. (October 2007). "Setting priorities in global child health research investments: assessment of principles and practice". Croatian Medical Journal. 48 (5): 595–604. PMC   2205967 . PMID   17948946.
  2. 1 2 3 Durand-Bourjate Y (February 2010). Setting Priorities in Health Interventions (PDF) (Report). Archived from the original (PDF) on 8 August 2016. Retrieved 5 July 2016.
  3. 1 2 "Call for Abstracts: Priority Setting for Universal Health Coverage" (PDF). Prince Mahidol Award Conference 2016. Retrieved June 23, 2016.
  4. 1 2 3 4 5 6 Rudan I, Kapiriri L, Tomlinson M, Balliet M, Cohen B, Chopra M (July 2010). "Evidence-based priority setting for health care and research: tools to support policy in maternal, neonatal, and child health in Africa". PLOS Medicine. 7 (7): e1000308. doi:10.1371/journal.pmed.1000308. PMC   2903581 . PMID   20644640.
  5. ↑ Shiffman J, Smith S (October 2007). "Generation of political priority for global health initiatives: a framework and case study of maternal mortality". Lancet. 370 (9595): 1370–1379. doi:10.1016/s0140-6736(07)61579-7. PMID   17933652. S2CID   5870284.
  6. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Glassman A, Chalkidou K, Giedion U, Teerawattananon Y, Tunis S, Bump JB, Pichon-Riviere A (March 2012). "Priority-setting institutions in health: recommendations from a center for global development working group". Global Heart. 7 (1): 13–34. doi: 10.1016/j.gheart.2012.01.007 . PMID   25691165.
  7. 1 2 3 Bloom BR, Michaud CM, La Montagne JR, Simonsen L (2006). "Priorities for Global Research and Development of Interventions". In Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al. (eds.). Disease Control Priorities in Developing Countries (2nd ed.). Washington (DC): World Bank. ISBN   978-0-8213-6179-5. PMID   21250329 . Retrieved 2016-06-30.
  8. 1 2 "A conversation with Amanda Glassman on November 13, 2013" (PDF). GiveWell. November 13, 2013. Retrieved June 21, 2016.
  9. ↑ "Centre for Population Health Sciences - People". September 30, 2015. Retrieved July 27, 2016.
  10. ↑ Sridhar D (2012-09-25). "Who sets the global health research agenda? The challenge of multi-bi financing". PLOS Medicine. 9 (9): e1001312. doi:10.1371/journal.pmed.1001312. PMC   3457927 . PMID   23049485.
  11. ↑ "Priority Setting". PHCPI. 2019-06-27. Retrieved 2022-05-28.
  12. ↑ Pratt B (May 2021). "Sharing power in global health research: an ethical toolkit for designing priority-setting processes that meaningfully include communities". International Journal for Equity in Health. 20 (1): 127. doi:10.1186/s12939-021-01453-y. PMC   8145852 . PMID   34034747.
  13. ↑ Norheim OF, Baltussen R, Johri M, Chisholm D, Nord E, Brock D, et al. (2014-08-29). "Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis". Cost Effectiveness and Resource Allocation. 12 (1): 18. doi:10.1186/1478-7547-12-18. PMC   4171087 . PMID   25246855.
  14. ↑ Baltussen R, Niessen L (August 2006). "Priority setting of health interventions: the need for multi-criteria decision analysis". Cost Effectiveness and Resource Allocation. 4 (1): 14. doi:10.1186/1478-7547-4-14. PMC   1560167 . PMID   16923181.
  15. ↑ Ruan K (2019). "Chapter 10 - Case Study: Insuring the Future of Everything: 10.5.2 Asymmetric Information". Digital Asset Valuation and Cyber Risk Measurement. London: Academic Press. pp. 159–167. doi:10.1016/B978-0-12-812158-0.00010-7. ISBN   978-0-12-812158-0.
  16. ↑ Mitton C, Donaldson C (April 2004). "Health care priority setting: principles, practice and challenges". Cost Effectiveness and Resource Allocation. 2 (1): 3. doi:10.1186/1478-7547-2-3. PMC   411060 . PMID   15104792.
  17. ↑ "The WHO Essential Medicines List (EML): 30th anniversary". World Health Organization. Archived from the original on May 27, 2014. Retrieved June 26, 2016.
  18. 1 2 3 "A systematic review of Demographic and Health Surveys: data availability and utilization for research". World Health Organization. September 1, 2011. Archived from the original on June 19, 2013. Retrieved July 20, 2016.
  19. 1 2 3 4 DiPrete B, Coffman D (March 2007). "A Brief History of Health Services Prioritization in Oregon" (PDF). Retrieved July 2, 2016.
  20. ↑ "Health Evidence Review Commission Prioritized List Overview". Oregon.gov. Retrieved July 2, 2016.
  21. ↑ "Health Research: Essential Link to Equity in Development" (PDF). Oxford University Press. 1990.
  22. 1 2 "About the Project" . Retrieved March 30, 2016.
  23. ↑ Paalman M, Bekedam H, Hawken L, Nyheim D (March 1998). "A critical review of priority setting in the health sector: the methodology of the 1993 World Development Report". Health Policy and Planning. 13 (1): 13–31. doi: 10.1093/heapol/13.1.13 . eISSN   1460-2237. PMID   10178182.
  24. ↑ Ruger JP (January 2005). "The changing role of the World Bank in global health". American Journal of Public Health. 95 (1): 60–70. doi:10.2105/AJPH.2004.042002. PMC   1449852 . PMID   15623860.
  25. ↑ "WHO - WHO-CHOICE". World Health Organization. Archived from the original on March 29, 2014. Retrieved June 23, 2016.
  26. ↑ "WHO - Who we are". World Health Organization. Archived from the original on March 30, 2014. Retrieved June 23, 2016.
  27. ↑ "Priority-Setting Institutions for Global Health". Center for Global Development . Retrieved June 21, 2016.
  28. ↑ Walker N, Tam Y, Friberg IK (2013). "Overview of the Lives Saved Tool (LiST)". BMC Public Health. 13 (3): S1. doi:10.1186/1471-2458-13-S3-S1. PMC   3847271 . PMID   24564438.
  29. ↑ "WHO's arrangement for hosting health partnerships and proposals for harmonizing WHO's work with hosted partnerships" (PDF). World Health Organization. January 18, 2013.
  30. ↑ "New Initiative Will Assess Disease Control Priorities In Developing Countries". Bill & Melinda Gates Foundation. September 2002. Retrieved June 21, 2016.
  31. ↑ "SIVAC Initiative". International Vaccine Institute. Retrieved June 26, 2016.
  32. 1 2 "About us". EVIDEM Collaboration. Retrieved July 19, 2016.
  33. ↑ "Decision criteria of the framework". EVIDEM Collaboration. Retrieved July 19, 2016.
  34. ↑ "International Decision Support Initiative awarded US$12.8m grant from the Gates Foundation". iDSI. January 30, 2016. Retrieved May 26, 2016.
  35. ↑ "National Institute for Health and Care Excellence". Bill & Melinda Gates Foundation. December 2015.
  36. ↑ Levine RE (March 2015). "Power in global health agenda-setting: the role of private funding Comment on "Knowledge, moral claims and the exercise of power in global health"". International Journal of Health Policy and Management. 4 (5): 315–317. doi:10.15171/ijhpm.2015.51. PMC   4417636 . PMID   25905483.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.